CD69 and neoplasm: 17.7 (±4.7)% and 17.1 (±6.5)% of the cells showed the expression of CD25 in PBL/PDL1-BiTE/tumor/ASCs or C.M. (P > 0.05, Figure 7(b)), whereas these percentages were 56.9 (±5.4)% and 64.3 (±8.4)% for CD69, respectively (P > 0.05, Figure 7(a)).